Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
U.S. FDA Grants VistaGen Therapeutics Fast Track Designation for PH94B ...
VistaGen and AffaMed Complete Key Regulatory Submissions for PALISADE ...
VistaGen Therapeutics Reports First Quarter Financial Results and ...
VistaGen Therapeutics logo in transparent PNG and vectorized SVG formats
Vistagen hi-res stock photography and images - Alamy
VistaGen Therapeutics (NASDAQ : VTGN) Analysis : r/pennystocks
VistaGen Therapeutics (NASDAQ:VTGN) Stock Price Passes Below 50 Day ...
VistaGen Therapeutics (NASDAQ : VTGN) Analysis : r/10xPennyStocks
Working at Vistagen Therapeutics | Great Place To Work®
VTGN | Vistagen Therapeutics, Inc. Common Stock Data, Price & News
Vistagen Announces Pricing of $100 Million Underwritten Offering ...
Buy VistaGen Therapeutics Stock – VTGN Stock Quote Today & Investment ...
VistaGen Therapeutics (VSTA) Featured in Exclusive Interview with ...
Vistagen has announced that the U.S. Patent and Trademark Office (USPTO ...
Revolutionizing mental health treatment: Vistagen Therapeutics' nasal ...
Vistagen Announces Issuance of U.S. Patent for PH80 Nasal Spray for ...
VISTAGEN - VistaGen Therapeutics, Inc. Trademark Registration
Vistagen Nears Critical CNS Milestone ‣ TradersQue
Buy VistaGen Therapeutics Inc. stock | $VTGN Share Price | Lightyear
What are the Porter's Five Forces of VistaGen Therapeutics, Inc. (VTGN ...
Fasedienol Nasal Spray: Vistagen Kicks Off Phase III Trial for Social ...
VistaGen Therapeutics: Buy Rating Backed by Promising Clinical Trials ...
VistaGen Therapeutics-VistaGen Therapeutics Inc.-企业详情-InvestGO数据库 ...
VistaGen finds open-label success with social anxiety nasal spray, but ...
Vistagen shares go through the roof on positive fasedienol trial resul ...
Vistagen today announced the broadening of its global intellectual ...
Vistagen Therapeutics recorta el 20% de su plantilla para sostener el ...
Vistagen Announces Topline Results from PALISADE-3 Phase 3 Public ...
Vistagen Initiates Phase 3 Trial of Fasedienol for Acute Social Anxiety ...
Maurizio Fava - Advisor at VistaGen Therapeutics | The Org
Vistagen Reports Positive Results from P-IIa Study of PH15 for ...
Vistagen Review - Pioneering Neuroscience & Groundbreaking 2024 ...
비스타젠 테라퓨틱스 ( VTGN) VistaGen Therapeutics, Inc. 상승하는 이유 (23.03.22) : 네이버 블로그
VTGN - Vistagen Therapeutics | Fundamentei
Why Is Vistagen Therapeutics (VTGN) Stock Up 650% Today? - YouTube
VistaGen readies Phase 3 trial of novel, fast-acting neuroactive nasal ...
VistaGen fails Phase 3 trial in social anxiety disorder - BioTuesdays
Vistagen Strengthens Its Neurology Focused Pipeline With Pherin Pharma ...
Vistagen - Concordia
VistaGen Therapeutics (VSTA) Makes Presentation on CardioSafe 3D ...
PESTEL Analysis of VistaGen Therapeutics, Inc. (VTGN) – DCFmodeling.com
VistaGen Therapeutics Advances New-Generation Antidepressant Approved ...
Vistagen has announced new itruvone (PH10) mechanism of action data ...
Vistagen Announces Positive Top-Line Results from Phase 3 PALISADE-2 ...
Vistagen and Fuji Pharma Co. Ltd. have entered into a time-limited ...
Vistagen Wins US Patent for Investigational NMDA Receptor Antagonist to ...
Vistagen will present posters highlighting fasedienol, its ...
VTGN Stock NEWS Alert! (buying? finally?) Vistagen Therapeutics - YouTube
Vistagen Email Format
تحليل مزيج التسويق لـ Vistagen Therapeutics ، Inc. (VTGN) – DCFmodeling.com
Vistagen will present two posters today during the American Society of ...
Vistagen Therapeutics, Inc. | Johnson Fistel
Vistagen股价大涨700%：社恐药三期临床成功 Armstrong 2023年8月7日， Vistagen 宣布Fasedienol ...
VistaGen Therapeutics, Inc. (VTGN): Business Model Canvas – DCFmodeling.com
FDA fast tracks Vistagen’s PH10 for major depressive disorder - BioTuesdays
7 Stocks Under $15 Predicted to Boom in the Next 2 Years
How Vistagen’s Nasal Spray for Social Anxiety Boosted Its Stock by ...
“社牛药”！Vistagen新药fasedienol达到3期临床试验终点，缓解社交焦虑症
Nasal Spray Shows Remarkable Efficacy in Easing Social Anxiety ...
Vistagen’s Breakthroughs: CNS Treatments to Watch in 2025
VistaGen's social anxiety nasal spray finds open-label success
Vistagen's Fasedienol: A Breakthrough for Social Anxiety Disorder on ...
VistaGen: Transformative Care, Revolutionary Relief ‣ TradersQue
Vistagen's new drug, Fasedienol, reaches Phase 3 clinical trial ...
FDA says "study may proceed" for Vistagen's refisolone nasal spray for ...
December 21 2022
Vistagen’s positive PhIII for social anxiety nasal spray pushes stock ...
Vistagen’s PH80 Nasal Spray Shows Promising Results in Menopausal Hot ...
Vistagen's late-breaking poster presentation at the American Society of ...
Join us in advancing transformative intranasal treatments that have the ...
Vistagen's Cancer Cachexia Nasal Spray Shows 71% Hunger Improvement in ...
Vistagen's PH80 demonstrated statistically significant efficacy versus ...
Vistagen’s on-demand nasal spray could provide a novel option for ...
VTGN (VistaGen Therapeutics, Inc.) – Technical Charts and Market Data ...
Vistagen新药fasedienol达到3期临床试验终点 - 知乎
